USA – The U.S. Department of Health and Human Services (HHS) has announced a significant investment of US $500 million into the development of universal vaccines aimed at providing broad protection against multiple strains of viruses, including influenza and coronaviruses. This initiative, termed “Generation Gold Standard,” represents a strategic pivot from previous COVID-19-specific projects to […]
USA – Novo Nordisk has announced partnerships with telehealth companies Hims & Hers Health, LifeMD, and Ro in a strategic move to bolster the availability of its weight-loss drug Wegovy. This collaboration aims to enhance Wegovy’s direct-to-consumer (DTC) sales, particularly as compounded versions of semaglutide face increasing regulatory restrictions following the resolution of previous drug […]
UK – AstraZeneca is contemplating a strategic shift in its manufacturing operations, considering relocating production of certain medicines from Europe to the United States. This move aims to mitigate potential impacts from anticipated U.S. import tariffs under President Donald Trump’s administration. Although pharmaceuticals are currently exempt, the looming threat has prompted proactive measures. CEO Pascal […]
SWITZERLAND – Swiss pharmaceutical giant Novartis has announced its plan to acquire Regulus Therapeutics, a San Diego-based biotech firm, in a deal valued at up to US $1.7 billion. The acquisition centers around Regulus’s experimental therapy, farabursen (formerly RGLS8429), aimed at treating autosomal dominant polycystic kidney disease (ADPKD), a prevalent genetic disorder leading to kidney […]
FRANCE – French deeptech startup Chipiron has raised US $17 million in a Series A funding round to advance the development of its miniaturized, portable MRI scanner. The investment aims to make MRI technology more accessible, particularly in underserved and remote areas. The funding round was led by Blast, with participation from the EIC […]
IRELAND – Medtronic has announced encouraging outcomes from its Spectrum Venous Leg Ulcer (VLU) study, highlighting the efficacy of the VenaSeal closure system in treating advanced superficial venous insufficiency (SVI). The single-arm study focused on patients with active venous leg ulcers (classified as CEAP C6), assessing the time to ulcer healing as the primary endpoint […]
USA – iCAD, Inc., a leader in AI-powered cancer detection, has announced a strategic collaboration with Microsoft to integrate its ProFound Breast Health Suite into Microsoft’s Precision Imaging Network. This partnership aims to enhance access to advanced AI-driven mammography solutions across more than 17,000 healthcare facilities nationwide. The collaboration will see iCAD’s ProFound AI […]
UK – GlaxoSmithKline (GSK) has reported stronger-than-expected first-quarter results and expressed confidence in its ability to manage potential U.S. pharmaceutical tariffs. The British drugmaker cited artificial intelligence (AI) initiatives and supply chain adjustments as key strategies to mitigate the impact of proposed trade measures. In the first quarter of 2025, GSK achieved a turnover of […]
AUSTRALIA – Australian biotechnology firm CSL Ltd is assessing whether its U.S.-manufactured surgical drugs, particularly human albumin, qualify for exemptions from China’s newly imposed 125% tariffs on American-made goods. This evaluation comes as the company seeks to mitigate the impact of escalating trade tensions between Beijing and Washington. China has discreetly granted tariff exemptions […]
UK — GSK has achieved a significant regulatory victory with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) granting approval for Blenrep (belantamab mafodotin) in combination therapies for relapsed or refractory multiple myeloma (RRMM). This marks the first global authorization for Blenrep in this new treatment setting, signaling a promising development for patients battling […]
USA — GE HealthCare Technologies has revised its full-year adjusted earnings per share (EPS) forecast for 2025, citing significant impacts from escalating global trade tensions and tariffs. The company now anticipates adjusted EPS between US $3.90 and US $4.10, down from the previous estimate of US $4.61 to US $4.75. This adjustment reflects an anticipated […]
USA — Gilead Sciences has agreed to pay US $202 million to resolve allegations that it provided illegal incentives to healthcare providers to promote its HIV medications, leading to fraudulent claims submitted to federal healthcare programs. The U.S. Attorney’s Office for the Southern District of New York announced that from 2011 to 2017, Gilead […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved